Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Antiviral Drugs. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101448838B details a novel catalytic route for HIV protease inhibitor intermediates, offering significant cost reduction and improved supply chain reliability for antiviral manufacturing.
Novel patent CN114671782A details a scalable synthesis of chiral halohydrin amines from L-phenylalanine, offering high purity and cost-effective manufacturing for antiviral intermediates.
Patent CN111087338B reveals a copper-catalyzed route for sulfonamide-substituted pyrrolidones, offering cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN108558776B reveals a green route replacing sulfuric acid with formic acid, enabling solvent recovery and waste reduction for reliable supply.
Discover the novel synthesis of potential antiviral intermediate BL via patent CN115894498A. Offers high diastereoselectivity and scalable manufacturing for global supply chains.
Patent CN115894498A reveals a high-yield route for antiviral intermediate BL. Discover cost-effective manufacturing and scalable supply chain solutions for nucleoside analogs.
Patent CN112481320B details a novel recombinant lactamase for producing optically pure (-)-γ-lactam. This breakthrough offers superior stability and stereoselectivity for antiviral drug synthesis.
Patent CN119977968A reveals a novel synthesis route for 2-amino-6-chloropurine with high yield and reduced wastewater, offering significant supply chain advantages.
Discover efficient chromone-based routes for high-purity pyrimidine derivatives. Enhance your antiviral pipeline with scalable, cost-effective pharmaceutical intermediates.
Patent CN113754694B reveals a novel chiral bicyclic imidazole catalyst method for Remdesivir. Achieve high-purity API intermediates with reduced manufacturing costs.
Patent CN113214263B reveals a high-yield synthetic route for Remdesivir key intermediates, offering significant cost reduction and scalable manufacturing for global pharmaceutical supply chains.
Patent CN112876524A reveals a scalable, high-yield route for Remdesivir intermediates, offering cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Patent CN111233870A details a column-free synthesis for Remdesivir intermediates, offering significant cost reduction and scalable manufacturing for global supply chains.
Patent CN113880901B reveals a metal-free asymmetric halocyclization route for high-purity nucleoside intermediates, offering significant cost reduction and supply chain reliability.
Novel Penicillium-derived monoamine oxidase enables high-concentration biocatalysis for antiviral drug intermediates, ensuring supply chain stability and cost efficiency.
Novel arabinose-based route reduces cost and improves scalability for high-purity antiviral intermediate manufacturing supply chains globally.
Novel patent CN120398868A offers high-yield Pritelivir synthesis with mild conditions ensuring supply chain stability and cost efficiency for pharmaceutical manufacturing.
Novel process for Favipiravir intermediate using microchannel technology reduces cost and enhances safety for reliable pharmaceutical intermediate supply chains.
Novel synthesis route for tenofovir intermediates offers high yield and cost reduction. Reliable supply chain for pharmaceutical manufacturing partners globally.
Patent CN106188193A reveals a novel N-protection strategy for Sofosbuvir intermediates, ensuring high purity, reduced impurities, and scalable manufacturing for global supply chains.